1 – 100 of 322
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Distinct Infiltration of T Cell Populations in Bladder Cancer Molecular Subtypes
(
- Contribution to journal › Article
- 2023
-
Mark
Protein Biomarker Signatures in Precision Diagnostics of Cancer
2023) p.487-505(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
An artificial intelligence-powered, patient-centric digital tool for self-management of chronic pain : a prospective, multicenter clinical trial
(
- Contribution to journal › Article
- 2022
-
Mark
Transcriptional profiling demonstrates altered characteristics of CD8 + cytotoxic T-cells and regulatory T-cells in TP53-mutated acute myeloid leukemia
(
- Contribution to journal › Article
-
Mark
One-year recovery from breast cancer : Importance of tumor and treatment-related factors, resilience, and sociodemographic factors for health-related quality of life
(
- Contribution to journal › Article
- 2021
-
Mark
The Value of a New Diagnostic Test for Prostate Cancer : A Cost-Utility Analysis in Early Stage of Development
(
- Contribution to journal › Article
-
Mark
Fluorescence signal enhancement in antibody microarrays using lightguiding nanowires
(
- Contribution to journal › Article
-
Mark
Identification of a serum biomarker signature associated with metastatic prostate cancer
(
- Contribution to journal › Article
-
Mark
Comprehending the proteomic landscape of ovarian cancer : A road to the discovery of disease biomarkers
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Psychological resilience and health-related quality of life in Swedish women with newly diagnosed breast cancer
(
- Contribution to journal › Article
-
Mark
Psychometric properties of the Connor-Davidson Resilience Scale (CD-RISC) in a non-clinical population in Sweden
(
- Contribution to journal › Article
-
Mark
Animal-derived-antibody generation faces strict reform in accordance with European Union policy on animal use
(
- Contribution to journal › Letter
-
Mark
Animal-free alternatives and the antibody iceberg
2020) In Nature Biotechnology(
- Contribution to journal › Letter
-
Mark
Multiplex profiling of serum proteins in solution using barcoded antibody fragments and next generation sequencing
(
- Contribution to journal › Article
-
Mark
Transcriptomic profiling of T-cell populations in non-muscle invasive and muscle invasive bladder cancer.
2020) The Society for Immunotherapy of Cancer's (SITC) 35th annual meeting In Journal for ImmunoTherapy of Cancer 8(Suppl. 3).(
- Contribution to journal › Published meeting abstract
- 2019
-
Mark
Skin Sensitization Testing-What's Next?
(
- Contribution to journal › Article
-
Mark
Digital twins to personalize medicine
(
- Contribution to journal › Scientific review
- 2018
-
Mark
A multicenter study investigating the molecular fingerprint of psychological resilience in breast cancer patients : Study protocol of the SCAN-B resilience study
(
- Contribution to journal › Article
-
Mark
Novel approaches to enzyme-immunoassay
2018) p.213-248(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Serum biomarker signature-based liquid biopsy for diagnosis of early-stage pancreatic cancer
(
- Contribution to journal › Article
-
Mark
Combination of phage and Gram-positive bacterial display of human antibody repertoires enables isolation of functional high affinity binders
(
- Contribution to journal › Article
- 2017
-
Mark
Testing human skin and respiratory sensitizers—what is good enough?
(
- Contribution to journal › Article
-
Mark
Precision diagnostics : moving towards protein biomarker signatures of clinical utility in cancer
(
- Contribution to journal › Scientific review
-
Mark
GARD : Genomic allergen rapid detection
2017) p.393-403(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Evaluation of the GARD assay in a blind cosmetics Europe study
(
- Contribution to journal › Article
-
Mark
Implementing liquid biopsies into clinical decision making for cancer immunotherapy
(
- Contribution to journal › Scientific review
-
Mark
Deciphering systemic lupus erythematosus-associated serum biomarkers reflecting apoptosis and disease activity
(
- Contribution to journal › Article
-
Mark
Tumor tissue protein signatures reflect histological grade of breast cancer
2017) In PLoS ONE(
- Contribution to journal › Article
- 2016
-
Mark
Advancing the global proteome survey platform by using an oriented single chain antibody fragment immobilization approach.
(
- Contribution to journal › Article
-
Mark
Plasma protein profiling in a stage defined pancreatic cancer cohort – Implications for early diagnosis
(
- Contribution to journal › Article
-
Mark
Generation and analyses of human synthetic antibody libraries and their application for protein microarrays
(
- Contribution to journal › Article
-
Mark
Animal-based antibodies : Obsolete
(
- Contribution to journal › Letter
-
Mark
Animal-Friendly Affinity Reagents : Replacing the Needless in the Haystack
(
- Contribution to journal › Scientific review
-
Mark
Technical advances of the recombinant antibody microarray technology platform for clinical immunoproteomics
(
- Contribution to journal › Article
-
Mark
Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma : a Nordic Lymphoma Group study
(
- Contribution to journal › Article
-
Mark
Evaluation of Solid Supports for Slide- and Well-Based Recombinant Antibody Microarrays
(
- Contribution to journal › Article
- 2015
-
Mark
Prediction of Chemical Respiratory Sensitizers Using GARD, a Novel In Vitro Assay Based on a Genomic Biomarker Signature.
(
- Contribution to journal › Article
-
Mark
Advanced technologies and diagnostic spin-outs: an interview with Carl Borrebaeck.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
A Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal Adenocarcinoma.
(
- Contribution to journal › Article
-
Mark
Combination of novel HER2-targeting antibody 1E11 with trastuzumab shows synergistic antitumor activity in HER2-positive gastric cancer.
(
- Contribution to journal › Article
- 2014
-
Mark
Molecular design of recombinant scFv antibodies for site-specific photocoupling to β-cyclodextrin in solution and onto solid support.
(
- Contribution to journal › Article
-
Mark
Generation of miniaturized planar ecombinant antibody arrays using a microcantilever-based printer.
(
- Contribution to journal › Article
-
Mark
Skin sensitizers differentially regulate signaling pathways in MUTZ-3 cells in relation to their individual potency.
(
- Contribution to journal › Article
-
Mark
Genomic Allergen Rapid Detection In-House Validation—A Proof of Concept
(
- Contribution to journal › Article
-
Mark
Antibody array generation and use.
(
- Contribution to journal › Article
- 2013
-
Mark
Nuclear T-STAR Protein Expression Correlates with HER2 Status, Hormone Receptor Negativity and Prolonged Recurrence Free Survival in Primary Breast Cancer and Decreased Cancer Cell Growth In Vitro.
(
- Contribution to journal › Article
-
Mark
Protein Expression Profiling of Formalin-Fixed Paraffin-Embedded Tissue Using Recombinant Antibody Microarrays
(
- Contribution to journal › Article
-
Mark
Modelling the benefits of early diagnosis of pancreatic cancer using a biomarker signature.
(
- Contribution to journal › Article
-
Mark
The GARD assay for assessment of chemical skin sensitizers.
(
- Contribution to journal › Article
-
Mark
Grading breast cancer tissues using molecular portraits.
(
- Contribution to journal › Article
- 2012
-
Mark
Expanded clinical and experimental use of SOX11-using a monoclonal antibody
(
- Contribution to journal › Article
-
Mark
Viewpoints in Clinical Proteomics - when will proteomics deliver clinically useful information?
(
- Contribution to journal › Article
-
Mark
Quantitative proteomics targeting classes of motif-containing peptides using immunoaffinity-based mass spectrometry.
(
- Contribution to journal › Article
-
Mark
Synergistic augmentation of CD40-mediated activation of antigen-presenting cells by amphiphilic poly(γ-glutamic acid) nanoparticles.
(
- Contribution to journal › Article
-
Mark
Epitope-specificity of recombinant antibodies reveals promiscuous peptide-binding properties.
(
- Contribution to journal › Article
-
Mark
Serum proteome profiling of pancreatitis using recombinant antibody microarrays reveals disease-associated biomarker signatures
(
- Contribution to journal › Article
-
Mark
Identification of serum biomarker signatures associated with pancreatic cancer
(
- Contribution to journal › Article
- 2011
-
Mark
A genomic biomarker signature can predict skin sensitizers using a cell-based in vitro alternative to animal tests
(
- Contribution to journal › Article
-
Mark
Histamine H(4) receptor antagonism inhibits allergen-specific T-cell responses mediated by human dendritic cells.
(
- Contribution to journal › Article
-
Mark
The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation
(
- Contribution to journal › Article
-
Mark
Design of recombinant antibody microarrays for membrane protein profiling of cell lysates and tissue extracts.
(
- Contribution to journal › Article
-
Mark
Surrogate antigens as targets for proteome-wide binder selection
(
- Contribution to journal › Article
-
Mark
Proteomic analysis and discovery using affinity proteomics and mass spectrometry.
(
- Contribution to journal › Article
-
Mark
Pattern rules: biomarker signatures for sensitization as an alternative to animal testing.
(
- Contribution to journal › Article
-
Mark
Knock-down of SOX11 induces autotaxin-dependent increase in proliferation in vitro and more aggressive tumors in vivo
(
- Contribution to journal › Article
-
Mark
Recombinant antibodies for the generation of antibody arrays.
(
- Contribution to journal › Article
-
Mark
Mimicking the immunoregulatory properties of primary dendritic cells in vitro − A rational approach to design a test system.
2011) p.67-86(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
The use of myeloid cell lines for the identification of allergens
2011) p.103-116(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases.
(
- Contribution to journal › Article
- 2010
-
Mark
Minimum information about a protein affinity reagent (MIAPAR)
(
- Contribution to journal › Letter
-
Mark
Immunomodulatory nanoparticles as adjuvants and allergen-delivery system to human dendritic cells: Implications for specific immunotherapy.
(
- Contribution to journal › Article
-
Mark
Fc epsilon RI levels and frequencies of peripheral blood dendritic cell populations in allergic rhinitis
(
- Contribution to journal › Article
-
Mark
Tissue proteome profiling of preeclamptic placenta using recombinant antibody microarrays
(
- Contribution to journal › Article
-
Mark
Plasma proteome profiling reveals biomarker patterns associated with prognosis and therapy selection in glioblastoma multiforme patients
(
- Contribution to journal › Article
-
Mark
A community standard format for the representation of protein affinity reagents
(
- Contribution to journal › Article
-
Mark
Two-step in vitro antibody affinity maturation enables estradiol-17β assays with more than 10-fold higher sensitivity.
(
- Contribution to journal › Article
-
Mark
Identification of uniquely expressed transcription factors in highly purified B-cell lymphoma samples.
(
- Contribution to journal › Article
-
Mark
SOX11 expression correlates to promoter methylatuion and regulates tumor growth in hematopoietic malignancies
(
- Contribution to journal › Article
-
Mark
Distribution, cellular localization, and therapeutic potential of the tumor-associated antigen Ku70/80 in glioblastoma multiforme.
(
- Contribution to journal › Article
- 2009
-
Mark
Design of high-density antibody microarrays for disease proteomics: Key technological issues.
(
- Contribution to journal › Article
-
Mark
The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer
(
- Contribution to journal › Article
-
Mark
Strategy for surveying the proteome using affinity proteomics and mass spectrometry.
(
- Contribution to journal › Article
-
Mark
Proteome Survey Using Affinity Proteomics and Mass Spectrometry
(
- Contribution to journal › Published meeting abstract
-
Mark
Implementing affinity proteomics into the clinic - diagnosis and prediction of metastatic breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
Safe cosmetics without animal testing? Contributions of the EU Project Sens-it-iv
(
- Contribution to journal › Article
-
Mark
Attovial-based antibody nanoarrays.
(
- Contribution to journal › Article
-
Mark
Antibody-based microarrays.
(
- Contribution to journal › Article
-
Mark
Identification of molecular targets associated with transformed diffuse large B cell lymphoma using highly purified tumor cells.
(
- Contribution to journal › Article
-
Mark
CD4+ T-cells have a key instructive role in educating dendritic cells in allergy
(
- Contribution to journal › Article
-
Mark
SOX11 but not SOX4 is a prognostic marker for improved recurrence free survival in epithelial ovarian cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma.
(
- Contribution to journal › Article
- 2008
-
Mark
Detection of pancreatic cancer using antibody microarray-based serum protein profiling
(
- Contribution to journal › Article
-
Mark
Functionally associated targets in mantle cell lymphoma as defined by DNA microarrays and RNA interference
(
- Contribution to journal › Article
-
Mark
Sensitivity of HIV-1 primary isolates to human anti-CD40 antibody-mediated suppression is related to co-receptor use
(
- Contribution to journal › Article
-
Mark
Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays.
(
- Contribution to journal › Article
-
Mark
Nuclear expression of the Non-B Cell Lineage Sox11 Transcription Factor Identifies Mantle Cell Lymphoma
(
- Contribution to journal › Article
-
Mark
Transformed diffuse large B cell lymphomas differ from follicular lymphomas in both gene and protein expression
2008) 10th International Conference on Malignant Lymphoma In Annals of Oncology 19(Suppl. 4). p.111-111(
- Contribution to journal › Published meeting abstract
-
Mark
antibody microarray analysis of directly labelled proteomes
(
- Contribution to journal › Scientific review
-
Mark
Phenotypic protein profiling of different B cell sub-populations using antibody CD-microarrays
(
- Contribution to journal › Article
-
Mark
Plasma Protein Biomarker Signatures As Indicators Of The Effects Of Immuno Gene Tumor Therapy In Patients With Glioblastoma Multiforme
2008) 8th Congress of the European-Association-for-Neuro-Oncology (EANO) In Neuro-Oncology 10(6). p.1131-1132(
- Contribution to journal › Published meeting abstract